These results suggest that the inhibition of STAT3 is not involved in the proliferation inhibitory effect or the downregulation of Mcl-1 and Bcl-2 induced by metformin and aspirin in the studied pancreatic cancer cells. Here, MCL1 is linked to pancreatic neoplasm.